What Is Considered a Low FSH Level?

An FSH level below roughly 1.5 to 2 mIU/mL in a reproductive-age adult is generally considered low, but context changes that number substantially. Your age, sex, the phase of your menstrual cycle if you menstruate, and even the specific laboratory running the test all shift the boundary between “normal” and “low.” Because FSH sits at the center of the hormonal chain that drives fertility and sexual development, a low reading can mean anything from a harmless timing artifact to a condition that needs treatment.

Why There Is No Single Universal Cutoff

Most commercial lab panels list a reference range for FSH, and those ranges vary from lab to lab. For adult men, a typical range runs from about 1.5 to 12.4 mIU/mL. For premenopausal women, the range shifts depending on menstrual cycle phase: it can dip as low as roughly 1.7 mIU/mL in the luteal phase and climb above 20 mIU/mL around ovulation. After menopause, FSH normally rises to 25 mIU/mL or higher, so a reading of 10 in a postmenopausal woman would be suspiciously low even though it falls squarely in the normal range for a younger woman.

A large part of the confusion is that the threshold between “normal” and “abnormally low” has never been standardized in the way that, say, blood glucose thresholds have. Research has shown that different statistical methods for choosing an FSH cutoff produce wildly different results, and using anything other than clinical-outcome-based methods to set that threshold can lead to inaccurate counseling.¹ In practical terms, this means your doctor interprets your FSH number alongside your symptoms, your other hormone levels, and your clinical picture rather than checking it against a bright line on a chart.

What FSH Does and Why Low Levels Matter

FSH is produced by the pituitary gland, a small structure at the base of the brain. Its release is controlled by a signaling molecule called GnRH, which pulses out of the hypothalamus. In women, FSH drives follicle growth in the ovaries; only follicles that receive adequate FSH stimulation can mature to the point of ovulation.² In men, FSH supports Sertoli cells in the testes, which are essential for producing sperm. When FSH is too low, neither process works properly.

The hormone operates in a feedback loop. The pituitary reads signals from the gonads (primarily estrogen and inhibin from the ovaries, testosterone and inhibin B from the testes) and adjusts FSH output accordingly. A low FSH level therefore usually points to a problem upstream, at the hypothalamus or pituitary, rather than at the gonads themselves. That distinction has big implications for diagnosis and treatment.

Central Versus Gonadal Problems

Doctors divide the causes of abnormal sex-hormone signaling into two broad categories. When the problem originates in the hypothalamus or pituitary, FSH and LH are inappropriately low. When the problem is in the gonads, the pituitary cranks out more FSH trying to compensate, so levels are high. A low FSH reading generally places the issue in the brain, not the ovaries or testes. This matters because the treatment strategies differ entirely.

The upstream category can stem from damage to the hypothalamus or pituitary (tumors, surgery, radiation), from medications that suppress the signaling pathway, or from functional suppression caused by things like severe stress or energy deficit. In the aging male population, a combination of both central and gonadal dysfunction becomes increasingly common.³ This overlap can make a single FSH value harder to interpret without additional testing.

Common Causes of Low FSH in Women

The most frequent reason premenopausal women develop low FSH is functional hypothalamic amenorrhea, sometimes shortened to FHA. In FHA, the hypothalamus slows or stops its pulsatile release of GnRH, which in turn shuts down FSH and LH production. The result is that periods stop and follicles stop maturing. The condition is driven by psychosocial stress, disordered eating, excessive exercise, or some combination of the three.⁴

Athletes are a classic at-risk group, but the older framing of “athletic amenorrhea” as a purely exercise-induced problem is misleading. The metabolic stress of heavy training and insufficient calorie intake acts alongside psychological stress, and these stressors amplify each other rather than operating in isolation.⁵ A woman who is training hard, undereating, and under emotional pressure from competition faces a triple hit to GnRH pulsatility. The good news is that FHA is usually reversible once the underlying stressors are addressed, whether through increased caloric intake, reduced training volume, stress management, or some combination.

Hormonal contraceptives are another common and entirely expected cause. Combined oral contraceptive pills, hormonal IUDs, and injectable progestins suppress GnRH pulsatility to varying degrees. A low FSH reading while you’re on these medications is by design and not a cause for concern on its own.

Common Causes of Low FSH in Men

In men, the most widespread iatrogenic cause of suppressed FSH is exogenous testosterone. Testosterone replacement therapy (TRT) feeds back to the hypothalamus and pituitary, telling them that enough sex hormone is circulating and that they can dial down GnRH, LH, and FSH. The degree of suppression depends on the delivery method. A review of the evidence found that long-acting injectable testosterone reduced FSH by about 86%, daily gels and patches by about 60%, and short-acting intranasal gel by about 38%.⁶

Anabolic-androgenic steroids produce the same effect, often more dramatically, because they flood the body with supraphysiologic doses of androgens. The resulting FSH suppression shuts down sperm production.⁷ Studies of men who abused androgens confirm that current users have markedly lower FSH, LH, and inhibin B compared to non-users, along with reduced testicular volume and poor sperm quality. The reassuring finding is that most of these changes appear to reverse after cessation, although mild reductions in testicular volume can persist.⁸

Medications and Substances That Suppress FSH

Beyond testosterone and anabolic steroids, several other medications can push FSH levels down by acting on the hypothalamic-pituitary axis.

• Opioids: Long-term opioid use for chronic pain or addiction frequently induces a state of low gonadotropins by centrally suppressing GnRH secretion.⁹ This can lead to low testosterone in men and menstrual irregularities in women, and may also trigger elevated prolactin and adrenal insufficiency.¹⁰
• GnRH agonists: Drugs like leuprolide and histrelin are used in prostate cancer treatment, endometriosis management, and puberty suppression. They initially cause a brief surge, then profoundly suppress FSH and LH. In transgender youth receiving histrelin implants, FSH levels dropped to under 1 mIU/mL on average.¹¹
• High-dose glucocorticoids: Chronic steroid use (prednisone, dexamethasone) can suppress the entire hypothalamic-pituitary axis, though the effect on gonadotropins is typically milder than with opioids or exogenous sex hormones.

If you’re on any of these medications and a blood test shows low FSH, the medication is the most likely explanation. Whether that matters clinically depends on your goals. For someone on palliative opioid therapy, mildly suppressed FSH may be a tolerable trade-off. For someone trying to conceive, it’s a problem that needs to be addressed.

Congenital and Genetic Causes

Some people are born with conditions that prevent normal FSH production. Kallmann syndrome is the most recognizable example. It involves a failure of GnRH-producing neurons to migrate to their proper location in the hypothalamus during fetal development, which means the pituitary never gets the signal to produce adequate FSH and LH. Affected individuals typically present with absent or incomplete puberty and, in many cases, a diminished or absent sense of smell.

More broadly, congenital hypogonadotropic hypogonadism can result from mutations in genes encoding the GnRH receptor, the FSH or LH beta-subunits, or various transcription factors needed for normal pituitary development.¹² These conditions are relatively rare but important to identify because they respond well to hormone replacement when recognized early.

Low FSH in Children and Adolescents

In children who have not yet entered puberty, FSH is naturally very low. That’s normal physiology, not a disease. The question becomes relevant when puberty is expected but doesn’t arrive. Delayed puberty is typically defined as no breast development by age 13 in girls or no testicular enlargement by age 14 in boys.

The most common explanation by far is constitutional delay of growth and puberty, a normal variant in which the whole pubertal timetable is simply shifted later. It accounts for roughly 60% of delayed puberty cases in boys and about 30% in girls.¹³ In these children, FSH is low simply because the hypothalamic clock hasn’t started ticking yet, and it will eventually rise on its own. Distinguishing constitutional delay from permanent hypogonadotropic hypogonadism (like Kallmann syndrome) can be genuinely difficult. A GnRH stimulation test can help, but it has real limitations, including inconsistent cutoff values across studies and unreliable results in the early phases of puberty.¹⁴

How Low FSH Affects Fertility

In women, the practical consequence of persistently low FSH is that follicles fail to mature. During a normal cycle, FSH rises in the late luteal and early follicular phase, creating a window during which a cohort of follicles can grow. The duration of that FSH window and how far FSH rises above a critical threshold determine how many follicles reach the preovulatory stage.² If FSH never reaches that threshold, ovulation doesn’t happen. This is why women with FHA stop ovulating and become infertile until the underlying cause is corrected.

In men, the consequences take longer to notice because testosterone, not FSH, drives libido and erectile function. A man with low FSH may feel fine and have a normal sex life but discover a problem only when a semen analysis comes back showing very few or no sperm. FSH is needed to maintain the Sertoli cells that nurse developing sperm through their maturation process. Without adequate FSH signaling, the whole assembly line stalls.

Treatment When FSH Is Too Low

The treatment depends entirely on the cause. When low FSH stems from a reversible stressor like energy deficit or opioid use, addressing the root cause is the first step. For women with FHA, restoring adequate nutrition and reducing exercise intensity often brings GnRH pulsatility back online, which in turn restores FSH and ovulation.

When the cause is permanent or when fertility is an immediate goal, direct hormone therapy comes into play. For men with hypogonadotropic hypogonadism who want to father children, the standard approach combines human chorionic gonadotropin (hCG), which mimics LH, with injectable FSH preparations. This combination has a strong track record of restoring spermatogenesis and enabling clinical pregnancy.¹⁵ Even at relatively low doses, recombinant FSH can induce sperm output capable of achieving fertilization in men who’ve been primed with hCG.¹⁶

For women with permanent hypogonadotropic hypogonadism who want to conceive, a similar strategy of exogenous gonadotropin injections (FSH with or without LH) can stimulate follicle development. Pulsatile GnRH delivery via a small pump is another option that more closely mimics normal physiology, though it’s not available everywhere.

For people who don’t need fertility but do need the downstream hormones for bone health, energy, and sexual function, simple sex-hormone replacement (estrogen/progesterone for women, testosterone for men) addresses the symptoms without trying to restart FSH production.

FSH Fluctuates More Than You Might Think

One reason a single FSH measurement can be misleading is that the hormone isn’t secreted at a steady rate. In men, FSH is released in pulses coupled with LH, and it has a circadian rhythm with higher levels in the morning and lower levels later in the day.¹⁷ In women, the variation across the menstrual cycle is even more dramatic. An FSH drawn during the mid-luteal phase will normally be much lower than one drawn in the early follicular phase. If your doctor ordered the blood draw at an unfortunate point in the cycle, the number might look low even though nothing is wrong.

This is why repeat testing matters. A single low FSH reading, especially if the blood was drawn in the afternoon or at a random point in the menstrual cycle, isn’t enough to diagnose anything. Most clinicians will confirm the result with a morning draw on day two or three of the cycle in women, or with a repeated morning sample in men, before acting on it.

FSH Receptors Outside the Reproductive System

For a long time, FSH was thought to matter only for the ovaries and testes. That picture has shifted. FSH receptors have been found on osteoclasts (the cells that break down bone) and on the endothelial cells lining blood vessels, raising the possibility that FSH influences bone density and cardiovascular health directly, not just through its effects on estrogen.¹⁸ Most of this research has focused on the menopausal transition, where rising FSH may contribute to bone loss and cardiovascular risk independently of falling estrogen. The clinical implications for people with chronically low FSH are less clear, and this remains an active area of investigation rather than established practice. Still, it’s a useful reminder that the hormonal milieu is interconnected in ways that extend well beyond fertility.